In the Media

November 1, 2018

UBC’s Dr. Yadav Talks about How Biosynthesis May Efficiently Produce Cannabinoids

InMed and the laboratory of Dr. Vikramaditya Yadav at the University of British Columbia collaborate on a proprietary biosynthesis technology to produce bioidentical, high purity, high grade cannabinoids. The host selected is E.coli. In this video, Dr. Yadav talks how an E.coli-based system is uniquely suited for producing cannabinoids.

Source: BTV

Share this post

Latest Articles

IntegraSyn™ – a flexible, high yield and cost-effective cannabinoid manufacturing system

InMed’s scientific team has developed IntegraSyn™ – a flexible, high yield and cost-effective manufacturing system to produce pharmaceutical-grade, bio-identical cannabinoids. InMed recently announced that IntegraSyn™

June 16, 2021

Cannabinol – charting new paths for glaucoma treatment

InMed Pharmaceuticals, a clinical stage pharmaceutical company based in Vancouver, Canada, is developing rare cannabinoid–based therapeutic drug candidates for patients who may benefit from the

June 2, 2021

Ensuring Cannabis safety – shifting from anecdotal to scientific evidence

Cannabis has been used for centuries, with evidence suggesting its medicinal use as early as 400 B.C. Interest in Cannabis’ potential medical benefits has garnered

May 12, 2021